JF
ALBO

Jump Financial’s Albireo Pharma Inc ALBO Stock Holding History

Jump Financial’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-11,700
Closed -$253K – 2191
2022
Q4 		$253K Buy
+11,700
New +$247K 0.01% 1144

Other funds holding ALBO

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Jump Financial's ALBO Position: Q1 2023 in Review

Jump Financial sold out of Albireo Pharma Inc (ALBO) in Q1 2023, closing a stake of 11,700 shares — an estimated $253K sold.

Jump Financial first reported a position in ALBO in Q4 2022 and held it in 1 quarter. The position peaked at $253K in Q4 2022. 3 funds tracked by Wall St. Rank hold ALBO as of Q1 2023.

  • Jump Financial reported no remaining Albireo Pharma Inc position as of Q1 2023 after selling out during the quarter.
  • Jump Financial sold 11,700 Albireo Pharma Inc shares in Q1 2023, an estimated $253K.
  • Jump Financial first reported a position in Albireo Pharma Inc in Q4 2022 and held it in 1 quarter.
  • Jump Financial's Albireo Pharma Inc position peaked at $253K in Q4 2022.
  • 3 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q1 2023.

Based on Jump Financial's 13F filing for Q1 2023, filed 3 May 2023.